Haw Financial Statements From 2010 to 2024

HAWPY Stock  USD 28.64  0.00  0.00%   
Haw Par financial statements provide useful quarterly and yearly information to potential Haw Par investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Haw Par financial statements helps investors assess Haw Par's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Haw Par's valuation are summarized below:
Haw Par does not presently have any fundamental trends for analysis.
Check Haw Par financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Haw Par's main balance sheet or income statement drivers, such as , as well as many indicators such as . Haw financial statements analysis is a perfect complement when working with Haw Par Valuation or Volatility modules.
  
This module can also supplement various Haw Par Technical models . Check out the analysis of Haw Par Correlation against competitors.

Haw Par Company Profit Margin Analysis

Haw Par's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Haw Par Profit Margin

    
  0.79 %  
Most of Haw Par's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Haw Par is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Haw Par has a Profit Margin of 0.7862%. This is 107.01% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The profit margin for all United States stocks is 161.91% lower than that of the firm.

Haw Par Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Haw Par's current stock value. Our valuation model uses many indicators to compare Haw Par value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Haw Par competition to find correlations between indicators driving Haw Par's intrinsic value. More Info.
Haw Par is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about  0.15  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Haw Par is roughly  6.73 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Haw Par by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Haw Par's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Haw Par Financial Statements

Haw Par investors use historical fundamental indicators, such as Haw Par's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Haw Par. Please read more on our technical analysis and fundamental analysis pages.
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company was incorporated in 1969 and is based in Singapore. Haw Par operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Haw Pink Sheet Analysis

When running Haw Par's price analysis, check to measure Haw Par's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haw Par is operating at the current time. Most of Haw Par's value examination focuses on studying past and present price action to predict the probability of Haw Par's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haw Par's price. Additionally, you may evaluate how the addition of Haw Par to your portfolios can decrease your overall portfolio volatility.